Indiana University Hospital
Indianapolis, Indiana, 46202, United States
Location status: Recruiting
NCT Number: NCT07290517
The goal of this clinical trial is to evaluate patient-reported pain, bleeding, and device efficiency along with provider satisfaction and ease of use between IUD insertions using a suction cervical stabilizer (new device, FDA approved, atraumatic) and single-tooth tenaculum (standard, traumatic). Our aims are to:
* assess and compare patient-reported pain during IUD insertion between the Carevix device and tenaculum. * assess predictors of pain scores including between nulliparous and multiparous patients * assess provider-reported ease of use and satisfaction
Participants (including providers) will:
* be randomized to receive one device to complete the IUD procedure * complete a survey following the procedure
Interested in participating?
Request Info18 year and older
Female
Interventional
Not applicable
Indianapolis, Indiana, 46202, United States
Location status: Recruiting
The primary objective is to assess and compare patient-reported pain during IUD insertion between the Carevix device and tenaculum. The hypothesis is that patient-reported pain scores comparing Carevix™ to tenaculum will be lower. The investigators will assess pain, and predictors for pain scores including nulliparous vs multiparous, when highest pain scores are reported, and expectation of pain for the procedure.
The secondary objective will be to assess Usability (provider assessment of ease of use, number of device placement attempts to secure sufficient traction on uterus), efficacy (ability to insert IUD with Carevix™ device alone without recourse to conventional tenaculum or other instruments), provider reported bleeding (cervical bleeding and ecchymosis), overall provider satisfaction, patient-reported pain scores at device placement prior to IUD insertion procedure and after completion of IUD insertion using Visual Analog Scale (VAS), overall patient satisfaction, and overall provider satisfaction. The investigators aim to expand the pilot trial data collection to assess cultural background, ethnicity and demographics while also assessing prior contraceptive choices, reasons for discontinuation of prior choices and reasons for current selection of IUD insertion and any anticipated barriers for removal.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
(to be assessed prior to procedure):
Exclusion criteria
(to be assessed by provider at time of procedure):
Vacuum cervical stabilization device
Standard of care cervical stabilization device
Time frame: During Procedure (at Cervix Grasping, at Cervix Traction, and at IUD placement)
Participants will be asked to rate their pain prior to, during, and after the IUD insertion procedure on a 0-10 scale, with zero meaning "no pain" and 10 meaning "the worst pain imaginable."
Time frame: Prior to procedure, during procedure (at cervix grasping, at cervix traction, at IUD placement), and 5 minutes after procedure completion
Participants will be asked to rate their pain prior to, during, and after the IUD insertion procedure on a 0-10 scale, with zero meaning "no pain" and 10 meaning "the worst pain imaginable." Pain scores will be compared among nulliparous and multiparous participants
Time frame: Prior to procedure, during procedure (at cervix grasping, at cervix traction, at IUD placement), and 5 minutes after procedure completion
Participants will be asked to rate their pain prior to, during, and after the IUD insertion procedure on a 0-10 scale, with zero meaning "no pain" and 10 meaning "the worst pain imaginable." The time at which the highest pain score was reported will be compared.
Time frame: Within 15 minutes after IUD procedure completion
Participants will be asked to rate their expectation of pain on a scale of 0-10, with 0 = no pain expected.
Time frame: Immediately after IUD procedure
Providers will be asked to provide their agreement that procedure time was not extended due to the device use on a 5 point Likert scale from "Strongly Disagree"-"Strongly Agree"
Time frame: Immediately after IUD insertion procedure
Providers will be asked whether the device's use impacted patient discomfort on a 5 point Likert scale from "Strongly Disagree"-"Strongly Agree."
Time frame: Immediately after IUD insertion procedure
Providers will be asked to rate their overall satisfaction with the device on a 5 point Likert scale from "Strongly Disagree"-"Strongly Agree"
Time frame: Immediately after IUD insertion procedure
Providers will be asked to rate visibility while using the device on a 5 point Likert scale from "Strongly Disagree"-"Strongly Agree"
Time frame: Immediately after IUD insertion procedure
Providers will be asked to rate the device's pulling strength as adequate on a 5 point Likert scale from "Strongly Disagree"-"Strongly Agree"
Time frame: Immediately after IUD procedure
Providers using the Carevix device will be asked to rate ease of use on a 5 point Likert scale from "Strongly Disagree"-"Strongly Agree."
Time frame: Immediately after IUD insertion procedure
Providers are asked to report the number of attempts required for device placement
Time frame: Immediately after IUD insertion procedure
Providers who use the Carevix device will be asked if the procedure's successful completion required replacing the Carevix device with the cervical tenaculum
Time frame: Immediately after IUD insertion procedure
The number of providers who had to manage or stop bleeding on cervical tissues will be compared.
Time frame: Immediately after IUD procedure completion
The time (minutes) required for the providers to stop bleeding of cervical tissues will be compared.
Time frame: Prior to Procedure and 5 minutes after procedure completion
Participants will be asked to rate their pain prior to, during, and after the IUD insertion procedure on a 0-10 scale, with zero meaning "no pain" and 10 meaning "the worst pain imaginable."
Time frame: Immediately after IUD procedure completion
Participants will rate their satisfaction with the procedure on a 5 point Likert scale from Very Dissatisfied to Very Satisfied.
Contact information is provided by the study sponsor or research team.
Alissa M Conklin, MD
CONTACT
Kylie L Williams, MA
CONTACT
Indiana University
Other
The Carevix Device: Assessing Pain and Effectiveness of a Suction-based Cervical Stabilizer for IUD Insertions in the Clinic Setting: a Randomized, Controlled Trial (CARE)
Acronym: CARE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04379102
Contraception, IUD
Istanbul, İ̇stanbul, Turkey (Türkiye)
View Trial DetailsNCT07295054
IUD
Toronto, Ontario, Canada
View Trial DetailsNCT06891794
IUD
Portland, Oregon, United States
View Trial DetailsNCT06240260
Acute Pain, Agnosia
Boston, Massachusetts, United States
View Trial Details